scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1006090516 |
P356 | DOI | 10.1038/BJC.2014.457 |
P932 | PMC publication ID | 4200097 |
P698 | PubMed publication ID | 25137020 |
P5875 | ResearchGate publication ID | 264866477 |
P50 | author | Norman Maitland | Q37392064 |
P2093 | author name string | A Noble | |
M Otsuka | |||
J Schmitt | |||
M G Rumsby | |||
P Berry | |||
P2860 | cites work | Measurement of Phospholipase D Activity | Q56029518 |
Abnormal Choline Phospholipid Metabolism in Breast and Ovary Cancer:Molecular Bases for Noninvasive Imaging Approaches | Q57738618 | ||
Importance of phosphatidylethanolamine for association of protein kinase C and other cytoplasmic proteins with membranes | Q67741637 | ||
Effect of ethanolamine on choline uptake and incorporation into phosphatidylcholine in human Y79 retinoblastoma cells | Q68965266 | ||
Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts | Q73248197 | ||
Cellular mechanism of sodium oleate-stimulated secretion of cholecystokinin and secretin | Q74070922 | ||
Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate | Q75247553 | ||
Fatty acid composition of phospholipids in epithelium and stroma of human benign prostatic hyperplasia | Q77155915 | ||
Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours | Q77707836 | ||
Epithelial cell motility is triggered by activation of the EGF receptor through phosphatidic acid signaling | Q82995091 | ||
Ethanolamine modulates DNA synthesis through epidermal growth factor receptor in rat primary hepatocytes | Q83161094 | ||
Phospholipase D in cell proliferation and cancer | Q28205631 | ||
Phosphorylation-dependent regulation of phospholipase D2 by protein kinase C delta in rat Pheochromocytoma PC12 cells | Q28211330 | ||
Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers | Q28217662 | ||
Hepatic phosphatidylethanolamine N-methyltransferase, unexpected roles in animal biochemistry and physiology | Q28249732 | ||
Phospholipase D | Q28253553 | ||
Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids | Q28265196 | ||
Phospholipase D: a lipid centric review | Q28270831 | ||
Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies | Q28284080 | ||
The methylation of phosphatidylethanolamine | Q28289280 | ||
Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40 | Q28306173 | ||
Phospholipase D1b and D2a generate structurally identical phosphatidic acid species in mammalian cells | Q28365884 | ||
Parathyroid hormone stimulates phosphatidylethanolamine hydrolysis by phospholipase D in osteoblastic cells | Q28574700 | ||
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer | Q30497364 | ||
Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. | Q30684622 | ||
Tumour phospholipid metabolism | Q33179622 | ||
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells | Q33699139 | ||
Phosphoethanolamine as a growth factor of a mammary carcinoma cell line of rat | Q33980710 | ||
Facilitation of phospholipase A2 activity by mastoparans, a new class of mast cell degranulating peptides from wasp venom | Q34056083 | ||
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. | Q34066911 | ||
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines | Q34095006 | ||
N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). | Q34098506 | ||
Sphingosine 1-phosphate, a key cell signaling molecule | Q34128454 | ||
Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics | Q34477513 | ||
Properties of the Group IV phospholipase A2 family | Q34543677 | ||
Cytosolic phospholipase A2-α expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours. | Q34543740 | ||
Mitogenic action of LPA in prostate | Q34691578 | ||
Lysophosphatidic acid as an autocrine and paracrine mediator | Q34691584 | ||
The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF). | Q35486098 | ||
Choline phospholipid metabolism: a target in cancer cells? | Q35549481 | ||
Protein kinase C-alpha in prostate cancer | Q35772647 | ||
The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein | Q35964273 | ||
Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component | Q36282450 | ||
Signaling functions of phosphatidic acid. | Q36436028 | ||
Phosphatidic acid- and phosphatidylserine-binding proteins | Q36453653 | ||
Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. | Q36607242 | ||
Ethanolamine modulates the rate of rat hepatocyte proliferation in vitro and in vivo | Q36655187 | ||
Expression and function of fatty acid amide hydrolase in prostate cancer. | Q36901770 | ||
Multi-targeted therapy of cancer by omega-3 fatty acids | Q36947010 | ||
Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer | Q37020802 | ||
Differential modulation of L-type calcium channel subunits by oleate | Q37092809 | ||
Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. | Q37100440 | ||
Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin | Q37110578 | ||
Advances in MR spectroscopy of the prostate | Q37300338 | ||
Molecular mechanisms of metastasis in prostate cancer | Q37339692 | ||
Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells | Q37380645 | ||
Occurrence, biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): not just precursors of N-acylethanolamines (NAE). | Q37875929 | ||
A decade in prostate cancer: from NMR to metabolomics | Q37876681 | ||
Lipids and prostate cancer | Q38002682 | ||
Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation | Q39054965 | ||
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines | Q39458740 | ||
Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C. | Q39602697 | ||
Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells | Q39836411 | ||
Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells | Q39937512 | ||
D609, an inhibitor of phosphatidylcholine-specific phospholipase C, inhibits group IV cytosolic phospholipase A2. | Q39952761 | ||
Comparison of radiolabeled choline and ethanolamine as probe for cancer detection | Q40009352 | ||
Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy. | Q40009485 | ||
CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells. | Q40019245 | ||
Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest | Q40214988 | ||
Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells | Q40275073 | ||
Alterations of choline phospholipid metabolism in ovarian tumor progression | Q40360938 | ||
Effects of econazole on Ca2+ levels in and the growth of human prostate cancer PC3 cells | Q40371030 | ||
Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF. | Q40456737 | ||
Inhibitors of protein kinase C. | Q40507552 | ||
Endogenous phospholipase D2 localizes to the plasma membrane of RBL-2H3 mast cells and can be distinguished from ADP ribosylation factor-stimulated phospholipase D1 activity by its specific sensitivity to oleic acid | Q40698369 | ||
Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells | Q40809642 | ||
Expression and regulation of phospholipase D isoforms in mammalian cell lines | Q40917037 | ||
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells | Q40979828 | ||
Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? | Q41035572 | ||
The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1beta (Rsk-2) and p70 S6 kinase. | Q41128592 | ||
Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study | Q41271051 | ||
Ethanolamine and choline transport in cultured bovine aortic endothelial cells | Q41404233 | ||
Binding of epidermal growth factor to its receptor is affected by membrane phospholipid environment. | Q41711407 | ||
The ethanolamine requirement of keratinocytes for growth is not due to defective synthesis of ethanolamine phosphoacylglycerols by the decarboxylation pathway | Q41787701 | ||
G protein-independent stimulation of human myocardial phospholipase C by mastoparan | Q41966245 | ||
Regulation of phospholipase D2 activity by protein kinase C alpha | Q42458821 | ||
Phorbol ester-stimulated hydrolysis of phosphatidylcholine and phosphatidylethanolamine by phospholipase D in HeLa cells. Evidence that the basal turnover of phosphoglycerides does not involve phospholipase D. | Q42473826 | ||
Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates | Q42477282 | ||
Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. Phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cells | Q42798711 | ||
Phorbol ester stimulates the hydrolysis of phosphatidylethanolamine in leukemic HL-60, NIH 3T3, and baby hamster kidney cells | Q42800167 | ||
Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis | Q42823337 | ||
Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties. | Q42824955 | ||
Phorbol ester selectively stimulates the phospholipase D-mediated hydrolysis of phosphatidylethanolamine in multidrug-resistant MCF-7 human breast carcinoma cells | Q42829171 | ||
Ethanolamine, but not phosphoethanolamine, potentiates the effects of insulin, phosphocholine, and ATP on DNA synthesis in NIH 3T3 cells--role of mitogen-activated protein-kinase-dependent and protein-kinase-independent mechanisms | Q42833186 | ||
Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer | Q42850126 | ||
Activation of betagamma subunits of G(i2) and G(i3) proteins by basic secretagogues induces exocytosis through phospholipase Cbeta and arachidonate release through phospholipase Cgamma in mast cells. | Q43775036 | ||
Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors | Q44161878 | ||
Anandamide and other N-acylethanolamines in human tumors | Q44233964 | ||
Mastoparan selectively activates phospholipase D2 in cell membranes | Q44295705 | ||
Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production | Q44441030 | ||
31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia | Q44673076 | ||
Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction | Q45185798 | ||
Cannabinoid receptor as a novel target for the treatment of prostate cancer | Q45309097 | ||
Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cells | Q46493494 | ||
Abnormal function of protein kinase C in cells having phosphatidylethanolamine-deficient and phosphatidylcholine-excess membranes. | Q52223973 | ||
The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras. | Q52539180 | ||
hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways. | Q53581949 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cancer cell line | Q23058136 |
P304 | page(s) | 1646-1656 | |
P577 | publication date | 2014-08-19 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6. | |
P478 | volume | 111 |
Q92354803 | Bacterial Microcompartment-Mediated Ethanolamine Metabolism in Escherichia coli Urinary Tract Infection |
Q39216218 | Diterpenes and Their Derivatives as Potential Anticancer Agents |
Q55192374 | Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering. |
Q47404758 | Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation |
Q47243959 | SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis |
Q36261136 | Synergistic Action of Genistein and Calcitriol in Immature Osteosarcoma MG-63 Cells by SGPL1 Up-Regulation. |
Search more.